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Abstract 
Exercise has been previously reported to lower cancer risk through reducing circulating 
IGF-1 and IGF-1-dependent signaling in mouse skin cancer models. This study is to investigate 
the underlying mechanisms by which exercise might impact IGF-1 pathway regulated by p53 
and p53-related proteins in mouse skin epidermis. Female SENCAR mice were pair fed an AIN-
93 diet with or without 10-week treadmill exercise at 20 m/min for 60 min daily. Animals were 
topically treated with TPA or vehicle control 2 hours before sacrifice and the target proteins in 
the epidermis were assessed by immunohistochemistry and Western blotting. Under TPA or 
vehicle treatment, MDM2 was significantly reduced in exercised mice compared with sedentary 
control. Meanwhile, p53 was significantly increased. In addition, p53 transcription target 
proteins p21, IGFBP-3, and PTEN were elevated in response to exercise. An interaction between 
exercise and TPA was observed on the decrease of MDM2 and increase of p53, but not p53 
down-regulated proteins. Taken together, exercise appears to activate p53 by reducing MDM2 
suppression, resulting in enhanced expression of p21, IGFBP-3 and PTEN that might further 
induce a negative regulation of IGF-1 pathway and therefore contribute to the observed cancer 
prevention by exercise in this mouse skin cancer model. 
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Chapter 1 - Literature Review 
 Overview of cancer and cancer prevention 
American Cancer Society estimated that the U.S. new cancer cases would increase to 
approximately 1.69 million in 2016 (American Cancer Society, 2016). Moreover, of all the 
cancer patients, about 1630 were predicted to die on a daily basis, representing nearly 1 in 4 
deaths in the U.S. (American Cancer Society, 2016). Cancer is characterized as uncontrolled 
growth and spread of abnormal cells (American Cancer Society, 2016). Cancer is a multifactor 
disease resulted from both non-modifiable factors such as age, gender, genetic family history, 
and modifiable factors such as tobacco use, dietary factors, and overweight (Kollarova et al., 
2014; Brown et al., 2012). Over the past decades, research regarding the impact of overweight on 
cancer is accumulating. It has been reported that 25% excess of normal body weight might 
contribute to a 33% higher cancer risk (Kritchevsky, 2003). Moreover, high body mass index 
(BMI) over 40 is associated with 50-60% higher cancer mortality rate compared to that in normal 
BMI (Calle et al., 2003). As such, weight control appears critical for cancer risk reduction.  
Research to date has developed physical activity and dietary caloric restriction as major 
weight control strategies with respect to cancer prevention. Physical activity and dietary caloric 
restriction seem to share no similarity, but they are both related to energy balance. A negative 
energy balance achieved by increasing energy expenditure via physical activity and/or reducing 
energy intake via dietary caloric restriction may contribute to cancer primary prevention. 
Physical activity refers to skeletal muscle movement with the classification of four 
subgroups, occupational activity, household activity, transport activity, and recreational or 
leisure-time activity (Caspersen et al., 1985). Exercise is under the subgroup of recreational or 
leisure-time activity, and can be identified into light, moderate, and vigorous exercise based on 
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the intensity (Thompson, et al., 2010). Scientific evidence of cancer prevention by physical 
activity is accumulating promptly. To date, numerous studies have demonstrated an inverse 
relationship between physical activity and the risk of various cancers, including breast cancer 
(Friedenreich, 2010), colon and colorectal cancer (Harriss et al., 2009; Slattery et al., 2003), 
pancreatic cancer (O’Rorke et al., 2010), prostate cancer (Patel et al., 2005; Liu et al., 2011), 
endometrial cancer (Voskuil et al., 2007), ovarian cancer (Olsen et al., 2007), lung cancer (Mao 
et al., 2003; Kubik et al., 2004), and others (Lee, 2003; Karim-Kos et al., 2008; Friedenreich and 
Orenstein, 2002). Despite the large number of scientific studies, the mechanisms by which 
physical activity may prevent cancer are not well established.  
 
Evidence of cancer prevention by physical activity 
Epidemiological studies  
The majority of epidemiological studies investigating the role of physical activity 
demonstrated a reverse association between physical activity and cancer risk, with a reduction 
rate of 10-50% (Kruk and Czerniak, 2013). As suggested by Friedenreich and Orensterin, the 
evidence of physical activity in cancer prevention is convincing for colon and breast cancer, 
probable for prostate cancer, possible for lung and endometrium cancer, and limited for other 
types of cancers (Friedenreich and Orensterin, 2002). A cohort study conducted in the U.S. with 
45,631women and an average follow-up of 8.9 years observed statistically significant decrease in 
breast cancer risk among those who exercised moderately (>10 hours per week of hiking or 
walking), when compared to non-exercised group (Howard et al., 2009). In another study among 
4,722 elder participants that developed colorectal cancer, those who engaged in moderate or 
vigorous exercise at least five times a week showed reduced colon cancer risk versus counterpart 
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control (Howard et al., 2008). In regard to the intensity of exercise, most studies reported a dose-
response effect that increased intensity and longer duration provided a greater protection effect 
(Friedenreich, 2010; Lynch et al., 2011). For example, the highest level of leisure-time physical 
activity reduced endometrial cancer risk by 27% versus the lowest level of physical activity 
(Voskuil et al., 2007). However, it remains unclear what type of physical activity and in which 
life period to start exercise are optimal for cancer prevention. It is suggested that 4-7 hours/week 
of moderate to vigorous physical activity is necessary to reduce cancer incidence (Thune and 
Furberg, 2001). In addition, an observational study predicted vigorous exercise at least 3 
hours/week might be sufficient to reduce prostate cancer mortality (Kenfield et al., 2011). 
Clinical trials 
The majority of observational studies have described a potential association between 
physical activity and cancer risk reduction, further clinical trials are necessary to establish 
causality. However, measuring cancer endpoints are challenging for investigators because the 
latency of cancer development requires a long follow-up duration. An alternative is to measure 
the changes of biomarkers related to cancer risk. The frequently examined biomarkers include, 
but not limited to, free estradiol, estradiol, estrone, testosterone, androstenedione, glucose, IGF-
1, IGFBP-3, leptin, and colon crypt (Winzer et al, 2011). Physical activity guidelines set up by 
American College of Sports Medicine (ACSM) suggested healthy adults, as well as cancer 
survivors, perform at least 30 min moderate intensity exercise daily for 5 days per week (Haskell 
et al., 2007; Schmitz et al., 2010). The American Institute for Cancer Research (AICR) and the 
World Cancer Research Fund (WCRF) recommend a minimum of 60 min moderate intensity or 
30 min vigorous intensity exercise per day to achieve cancer risk reduction (World Cancer 
Research Fund / American Institute for Cancer Research, 2007). The exercise interventions in 
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randomized clinical trials are developed based on the ACSM or AICR/WCRF guidelines; the 
control groups in general received “usual care”. Plausible results from clinical trials reported a 
preventive effects of exercise on cancer through modifications of sex hormones (Friedenreich et 
al., 2010; Campbell et al., 2012). For example, a two-center, two-arm randomized controlled trail 
including 320 postmenopausal, sedentary women showed significant decrease in free estradiol 
and estradiol and increase in SHBG compared to control group after exercise intervention for 12 
months (Friedenreich et al., 2010). However, there exists trials that reported no significant 
difference in selective sex hormones after exercise treatment. McTiernan et al. did not observe 
overall differences in estrone, estradiol, and free estradiol between exercise and control groups 
after a 12-month exercise intervention; significance were only found among individuals who lost 
at least 2% of baseline body fat (McTiernan et al., 2004). Thus, further studies are warrant to 
assess the effectiveness and mechanisms of physical activity on cancer prevention. 
Animal studies 
As a complement to clinical trials, the utilization of animal models facilitates the 
investigation of exercise-induced cancer prevention mechanisms. Exercise has been associated 
with the inhibition of chemically induced carcinogenesis in plenty of animal studies. Voluntary 
wheel running plus swimming for 21days remarkably decreased Walker 256 tumor weight 
among male Wistar mice (Hoffman et al., 1962). Zielinski et al. observed delayed lymphoma 
tumor growth in Female BALB/c mice following strenuous treadmill exercise in comparison to 
sedentary control mice (Zielinski et al., 2004).The onset and size of tumors were inhibited in an 
ultraviolet B induced mouse skin cancer model after voluntary running wheel exercise (Michna 
et al., 2006). In another study, F344 male rats subjected to treadmill exercise (120 min/d, 10 
m/min, and 5 d/week) developed significantly less colon tumors compared to non-exercise group 
5 
(Fuku et al., 2007). A very recent study found treadmill running (60 min/day, 5 days/week for 32 
weeks) decreased the number and volume of liver tumor in male hepatocyte-specific PTEN-
deficient (AlbCrePtenflox/flox) mice (Piguet et al., 2015). However, no significant effect on 
DMH induced colon tumor incidence was found in male Wistar rats under swim training 20 
min/d, 5 d/week for 35 week and those in control group (Lunz et al., 2008). There were also 
studies reported increased cancer risk after exercise training. Sprague-Dawley rats induced by 
breast carcinogenesis experienced a 200% increase in tumor growth rate versus sedentary control 
after intense swimming for 38-65 days, despite no significance in overall survival time (del 
Carmen Sáez et al. 2007). The mixed results may be attributed to the differences in exercise 
protocols and the gender of animals. As supported by Mehl et al., the crypt depth-to-villus height 
ratio decreased significantly for mice exercise by treadmill running rather than wheel running 
(Mehl et al. 2005). It was also found that male but not female ApcMin/+ mice showed significant 
decrease in the number of large polyps after treadmill exercise. Additionally, the intensity of 
exercise may also impact the results. It has been hypothesized that extreme high level of exercise 
may lead to oxidative stress that increase DNA damage and inflammation (Poulsen et al. 1996; 
Poulsen et al. 1999; Cooper et al. 2002). The impact of physical activity on cancer prevention in 
animal studies is less consistent than that in epidemiological studies and clinical trials. 
 
Potential cancer prevention mechanisms by physical activity 
Alteration of growth factors 
Growth factors such as insulin-like growth factors (IGFs) have received increasing 
attention in physical activity promoted cancer prevention due to their significant role in cell 
growth and anti-apoptosis. IGF-1 is a polypeptide that has sequence highly similar to insulin. 
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The level of circulating IGF-1 is modulated by its binding proteins (IGF-BPs). When IGF-1 is 
bound to corresponding receptors, the downstream auto-phosphorylation is activated, resulting in 
activation of PI3K-Akt-anti-apoptosis cascades (Jiang and Wang, 2008). It has been reported that 
high circulating IGF-1 levels in serum were associated with higher premenopausal breast cancer 
risk in Chinese women (Yu et al., 2002). Moreover, a prospective case-control study nested in 
the Physicians' Health Study found men in the highest IGF-I quintile had an elevated risk of 
colorectal cancer compared to those in the lowest quintile (Ma et al., 1999). 
Given the fact that increased IGF-1 level is associated with higher risk of cancer, 
reducing bioavailable IGF-1 may be critical in cancer prevention. Rosendal et al. demonstrated 
an inverse relationship between physical training and circulating IGF-1 and IGF binding proteins 
(IGFBPs) in a human study (Rosendal et al. 2002). In this study, seven untrained and twelve 
well-trained young men received a 10-week intensive exercise training. As a result, total IGF-I, 
circulating IGF-I, and IGFBP-4 were decreased in both groups. Previous study in our lab 
observed significant decrease in IGF-1 level following treadmill exercise in skin carcinogenesis 
mice (Xie  et al., 2007). These results supported that reduced IGF-1 levels and the corresponding 
IGF-1 down-regulation may be responsible for anti-tumorigenic mechanisms. 
Reduction of oxidative stress  
It is well known that oxidative stress is associated with aging and various chronic 
diseases. The increased reactive oxygen species are the cause of protein and lipid damage, as 
well as DNA mutation, which may further lead to tumor cell proliferation (Westerlind, 2003). 
Many studies have pointed moderate physical activity to reduced oxidative stress. In a study 
using mouse model, moderate treadmill exercise was reported to significantly prevent aging-
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associated oxidative stress by preventing decrease in bioactivity of antioxidant enzymes and 
mitochondrial NADH-cytochrome-c reductase (Navarro et al., 2004).  
Regulation of sex hormones 
The level of serum sex hormones, such as oestrogens and the protein sex hormone-
binding globulin (SHBG), are related to risk of post-menopausal breast cancer. It has been 
consistently observed that postmenopausal women with highest sex hormone levels showed up to 
two-fold elevated breast cancer risk compared with those in the lowest quintile (Key et al., 2002; 
Kaaks et al., 2005). A recent intervention trial on postmenopausal overweight and physical 
inactive women observed significant decrease in serum sex hormones and SHBG after 16-week 
intensive exercise (van Gemert et al., 2015). In an animal study, five out of sixteen female 
Harlan Sprague-Dawley rats showed reduced estradiol levels (Caston et al., 1995). Exercise is 
concluded to be able to alter anterior pituitary gonadotrope, thus impact estrous cycles of rats.  
Reduction of inflammation 
Chronic inflammation has been revealed to increase cancer incidence by promoting 
abnormal cell growth and tumor development (Brown et al., 2012). Biomarkers associated with 
cancer risk include C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α 
(TNF-α). An analysis involved in 14,461 U.S. adults estimated those who reported to participate 
in vigorous intensity physical activity (≥500 MET·min·wk-1) have significantly lower rate in 
CRP increase compared to physical inactive adults (Richardson, et al., 2015). In an intervention 
study, 120 premenopausal and obese women were assigned to low-energy diet, exercise, and 
control group, respectively, a 2-year intervention resulted in decreased circulating levels of IL-6, 
IL-18 and CRP when compared to control group (Esposito et al., 2003).  
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Proteins critical for cancer prevention 
There are several proteins that play a key role in cancer induction and development. The 
development of cancer is caused by the mutation of genes such as oncogenes and tumor 
suppressor genes, which encode a variety of proteins that regulate cell growth and proliferation.  
P53 is a well-known tumor suppressor protein that is critical in genomic stability, DNA damage 
repair, and cell cycle arrest (Feng and Levine, 2010). Under normal condition, the p53 protein is 
maintained at low level due to the negative regulation by MDM2, an E3 ligase that promotes the 
degradation of p53 (Moll and Petrenko, 2003). However, when DNA damage occur, the p53 
protein can be activated with an increase in level and elevation in ability to transcript down-
stream proteins such as p21, IGFBP-3, and PTEN (Lakin and Jackson, 1999). P21 is a 
cyclin/CDK cascade inhibitor. The p53 works together with p21 to arrest cell cycle at G1 
(Waldman et al., 1995), therefore prevent cell growth during cancer development. IGFBP-3 and 
PTEN are regulators of IGF-1-dependent pathways. IGFBP-3 is a binding protein that regulates 
bioavailable IGF-1 levels. In human body, IGFBP-3 is the most abundant in IGF binding protein 
family and accounts for approximately 90% of IGF-1 binding in serum, forming a large complex 
that prevents IGF-1 transporting out of bloodstream (Jiang et al., 2008). A reduction in 
bioavailable IGF-1 has been associated with reduced cancer risk (Xie et al., 2007). PTEN is 
known to retain IGF-1-PI3K-Akt pathway by dephosphorylating phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) back to phosphatidylinositol 4,5-bisphosphate (PIP2) (Lu et al., 2006).  A 
negative regulation of IGF-1-Akt pathway is related to enhanced apoptosis of abnormal cells.  
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Conclusion 
Cancer is developed due to uncontrolled growth and spread of abnormal cells. Many 
modifiable factors including overweight may contribute to cancer incidence. Human and animal 
studies have suggested an association between physical activity and cancer risk reduction. 
However, the underlying mechanisms remain unclear. Hypothesized molecular mechanisms 
include regulation of growth factors and sex hormones, mitigation of oxidative stress, DNA 
repair, and reduction of inflammation. Study by others and in our lab found a potential role of 
exercise in decreasing bioavailable IGF-1 and IGF-1-dependent pathway, but the regulators 
involved in this pathway have not been identified. Tumor suppressor proteins play a critical role 
in cancer prevention and seem to be associated with IGF-1 network. Therefore, the aimed of this 
thesis study is to identify critical proteins involved in IGF-1 pathway regulation, thus provide 
further insight into the mechanisms of exercise-promoted cancer prevention. 
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Chapter 2 - Experiment 
Abstract 
Exercise has been previously reported to lower cancer risk through reducing circulating 
IGF-1 and IGF-1-dependent signaling in mouse skin cancer models. This study is to investigate 
the underlying mechanisms by which exercise might impact IGF-1 pathway regulated by p53 
and p53-related proteins in mouse skin epidermis. Female SENCAR mice were pair fed an AIN-
93 diet with or without 10-week treadmill exercise at 20 m/min for 60 min daily. Animals were 
topically treated with TPA or vehicle control 2 hours before sacrifice and the target proteins in 
the epidermis were assessed by immunohistochemistry and Western blotting. Under TPA or 
vehicle treatment, MDM2 was significantly reduced in exercised mice compared with sedentary 
control. Meanwhile, p53 was significantly increased. In addition, p53 transcription target 
proteins p21, IGFBP-3, and PTEN were elevated in response to exercise. An interaction between 
exercise and TPA was observed on the decrease of MDM2 and increase of p53, but not p53 
down-regulated proteins. Taken together, exercise appears to activate p53 by reducing MDM2 
suppression, resulting in enhanced expression of p21, IGFBP-3 and PTEN that might further 
induce a negative regulation of IGF-1 pathway and therefore contribute to the observed cancer 
prevention by exercise in this mouse skin cancer model.  
 
Introduction 
Physical inactivity, together with smoking and high calorie diet, is a main modifiable 
factor that contributes to cancer development (Friedenreich and Orenstein, 2002). Scientific 
evidence for primary cancer prevention through physical activity is accumulating promptly. To 
date, large epidemiological studies and clinical trials have demonstrated that physical activity is 
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effective in reducing the risk of various cancers, including breast cancer, colon and colorectal 
cancer, pancreatic cancer, prostate cancer, endometrial cancer, ovarian cancer, and lung cancer, 
with a reduction rate of  10- 50% (Friedenreich et al., 2010; Winzer et al., 2011; Kruk and 
Czerniak, 2013). A cohort study with 45,631 U.S. women and an average follow-up of 8.9 years 
observed statistically significant decrease in breast cancer risk among those who exercised 
moderately (>10 hours per week of hiking or walking), when compared to no hiking or walking 
group (Howard, et al, 2009). In addition to human studies, exercise intervention studies 
conducted in animal models also  showed protective effects against PTEN-deficient mouse liver 
tumors (Piguet et al., 2015), DNH-induced rat colon cancer (Lunz et al., 2008), and UVB-
induced mouse skin cancer (Michna et al., 2006). Previous study in our lab observed reduced 
skin cancer risk in exercised mice fed with iso-caloric diet comparable to sedentary control (Xie 
et al., 2007).  
Although exercise has been associated with cancer prevention, the underlying 
mechanisms are not well established. The current hypothesized mechanisms through which 
exercise might reduce cancer risk include hormone regulation, inflammation reduction, immune 
function enhancement, and DNA repair, etc. (Rundle et al., 2005). Specifically, mitogenic 
hormones such as IGF-1 have been related to elevated risk of multiple cancers (Yu et al., 2002; 
Ma et al., 1999). IGF-1 is known to trigger cell proliferation and inhibit apoptosis. When binding 
to corresponding receptors, IGF-1 is able to activate downstream networks including Ras-MAPK 
proliferation and PI3K-Akt anti-apoptosis, resulting in cancer development (Benito et al., 1996). 
In animal study, such activation can be stimulated by 12-O-tetradecanoylphorbol-13-acetate 
(TPA), a phorbol ester commonly used for skin carcinogenesis promotion in mouse model 
(DiGiovanni, 1992). When applied to mice epidermis, TPA is accepted by a calcium-activated, 
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phospholipid dependent serine/threonine kinase protein kinase C (PKC) (Ashendel, 1985). The 
PKC isoforms then activate the Ras-regulated downstream networks, particularly the MAPK 
cascade, leading to tumor cell growth (Schönwasser et al., 1998; Corbit et al., 2000). Studies in 
our laboratory found exercise plus an iso-caloric diet with counterpart control significantly 
decreased circulating IGF-1 level and IGF-1 signaling in a TPA-induced skin cancer mouse 
model (Xie et al., 2007; Standard et al., 2014). Due to the significant role of IGF-1 in cell growth 
and survival, inhibiting IGF-1 signaling appears to be a critical target for cancer prevention. 
However, the possible up- and down- stream proteins that regulate IGF-1 signaling and 
the IGF-1 pathways with respect to exercise were not identified. Studies have demonstrated a 
potential connection between p53 protein and IGF-1 pathways in a caloric restriction-induced 
anti-aging study (Tucci, 2012). P53 is a tumor suppressor gene essential for DNA repair and 
gene stabilization. Furthermore, as a transcription factor, p53 has a sequence-specific DNA-
binding domain in the central region and a transcription activation domain at N terminus (Ko and 
Prives, 1996). In normal cells, p53 is maintained at a low concentration by its negative regulator 
MDM2 protein, a ring finger ubiquitin ligase that bind with p53, forming a complex that triggers 
p53 degradation (Fang et al., 2000; Moll and Petrenko, 2003). However, upon DNA damage, p53 
is released from MDM2 through phosphorylation (Ashcroft et al., 2000). Activated p53 then 
selectively stimulates the transcription of its target genes, such as p21, IGFBP-3, and PTEN to 
initiate cellular apoptosis and cell cycle arrest (Stambolic et al., 2001; Grimberg, 2000; Waldman 
et al., 1995). It has been shown that p53 gene is effective in protecting mice against UV-induced 
cancer (Jiang et al., 1999). 
The current study investigated moderate exercise-induced cancer prevention by p53 
activated down-regulation of IGF-1 pathway in TPA promoted SENCAR mice. P53 up-
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regulation protein and transcription proteins involved in IGF-1 pathway modulation were 
assessed by immunohistochemistry and Western blotting. The aim of this study is to provide 
further insight into the cancer prevention mechanisms through exercise. 
 
Materials and methods 
Animals and treatment 
Six-week old female SENCAR mice from National Institutes of Health (Frederick, MD) 
were housed individually at 24  1 ˚C with a 12:12 light-dark cycle. Mice were randomly 
assigned into one of two groups: ad libitum feeding sedentary control and exercise but pair 
feeding of the same amount as sedentary control (AIN-93 diet). After a two-week adaptation 
period for the new environment or treadmill exercise accordingly, animals in exercise group 
were trained on a zero-grade adjustable-speed mouse 5-lane treadmill (Harvard Apparatus, 
Holliston, MA) at 20 m/min, 60 min/day and 5 days/week for 10 weeks. At the end of the 
experiment, the mice dorsal skin was shaved and treated with TPA at 3.2 nmol in 200 μL of 
acetone or acetone only. The mice were sacrificed two hours after TPA or vehicle acetone 
treatment. Skin tissues were then snap-frozen in liquid nitrogen and stored at -80 ˚C for further 
analysis of targeted proteins by immunohistochemistry (IHC) and Western blotting. 
Protein analysis by IHC 
The frozen mice dorsal skin tissues were fixed in 3.7% formalin for 22 hours at -70 ˚C 
and then switched to 70% ethanol. The skin tissues were set on edge in paraffin blocks, sectioned 
at a thickness of 4 micrometers, and then placed on slides. For immunostaining, sections were 
deparaffinized twice in Master Clear (American MasterTech Scientific) for 10 min, followed by 
rinsing in absolute alcohol for 1 min. Slides were subsequently placed in 30% H2O2 in methanol 
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for endogenous peroxidase quenching for 20 min.  Sections then underwent rehydrated through 
100%, 95%, 75%, and 50% ethanol, and were finally placed in distilled water. Antigens were 
retrieved by steaming in citrate buffer for 20 min. After PBST washes, sections were incubated 
overnight at 4 ˚C, with 1: 160 dilution in PBST for rabbit p53 primary monoclonal antibody 
(Santa Cruz Biotechnology Inc., Santa Cruz, CA ) and 1: 50 dilution for other rabbit against 
mouse MDM2, IGFBP-3, PTEN antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, CA), 
respectively. Control sections were incubated with 5% BSA in PBST only. Alexa Fluor 555 goat 
anti-rabbit IgG secondary antibody ( Life Technologies, Carlsbad, CA) were applied to both 
samples and negative controls with a dilution of 1:500 at 37 ˚C for 60 min. Images were obtained 
using a LSM-5 confocal microscopy and analyzed using Image J software (Jena, Germany). The 
IHC images were quantified by deducting fluorescence intensity of controls from that of samples 
to eliminate the background stain.  The sample size for each group was four. 
Protein analysis by Western blotting 
Mouse skin tissues were sliced and placed in 600 μL ice-cold PBS containing PMSF 
(1:100). After sonicating for 15s, samples were centrifuged at 7,000 rpm for 5 min at 4 ˚C. The 
supernatants were removed and 250 μL of RIPA buffer (50 mM Tris HCL at pH 8.0, 150 mM 
NaCl, 0.5% Sodium Deoxycholate, 0.1% SDS, and fresh PMSF) were added to samples for 
incubation for 30 min with vortexing every 5 min. The tissue samples were then centrifuged at 
13,000 rpm for 15 min at 4 ˚C. The supernatants containing soluble proteins were transferred to a 
new tube. The protein extraction from pellet was performed one more time with 100 μL of RIPA, 
The supernatants from the first and second extractions were combined. Protein concentrations 
were measured using Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). Whole 
cell protein 30 μg was electrophoresed on mini-protein TGX gels (Bio-Rad Laboratories, 
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Hercules, CA) at a voltage of 90 V for 90 min. The protein bands were then transferred to a 
nitrocellulose membrane, where the transferred bands corresponding to MDM2 at 90 kDa, p53 at 
53 kDa, p21 at 21 kDa, IGFBP-3 at 40/44 kDa, PTEN at 55 kDa, and β-actin at 43 kDa were 
respectively bound to rabbit monoclonal antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, 
CA). Subsequently, the bound proteins were incubated with Thermal Scientific Pierce anti-rabbit 
secondary antibody (Rockford, IL). Protein bands were visualized and quantified using 
FluorChem™ 8900 Advanced Imaging System (Alpha Innotech, San Leandro, CA). The band 
density was standardized to the loading control β-actin. Afterwards, the band density of all four 
experimental groups were divided by that of Acetone sedentary control for adjustment and 
reported as relative density. Sample size for each group was four. 
Statistical analysis  
Student t-test was performed to analyze the significance of protein expression between 
sedentary control and exercise group. Two-way analysis of variance (ANOVA) was performed 
to assess the interaction between exercise and TPA induction. Minimum significance level was 
set at 0.05.  
 
Results 
Effects of exercise on the expression of protein MDM2 and p53 
IHC Images of protein MDM2 fluorescence intensity quantified by Image J were shown 
in Figure 2-1A. The protein levels were calculated by the fluorescence intensity with respect to 
the brightness and amount of red stain. When SENCAR mice were treated with acetone vehicle 
only, MDM2 fluorescence intensity of exercised mice was significantly decreased by 44% in 
comparison with sedentary control. Similarly, exercised mice with TPA treatment showed a 
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decrease of 47% compared to the counterpart control group. This significant decrease of MDM2 
determined by IHC was confirmed by Western blotting results (Figure 2-1B). A significant 
decrease of MDM2 expression by 41% and 34% was observed within exercise group treated with 
acetone and TPA, respectively. Opposite to MDM2, the IHC fluorescence intensity of p53 
protein showed prominently increase (59%) in exercise group treated with acetone only (Figure 
2-2A). Furthermore, this increase became dramatic after TPA treatment, with a large increase by 
159% (exercised vs. sedentary mice). Western blotting showed a similar enhancement of p53 
expression in exercise group under both Acetone and TPA treatment (Figure 2-2B).  
Effects of exercise on the expression of p53 transcription proteins  
The expression of p53 downstream proteins p21, IGFBP-3, and PTEN were also assessed 
by both IHC and Western blotting. Elevated levels of all the three proteins were observed in 
exercise group when compared with the corresponding sedentary control with or without TPA 
treatment. As is shown in Figure 2-3, the p53 direct transcription target protein p21showed a 
statistical enhance by 121% in IHC and 29% in Western blotting in exercised mice treated with 
acetone. Similarly, p21 was increased by 30% in IHC and 39% in Western blotting in exercised 
mice treated with TPA. For IGFBP-3 (Figure 2-4), a slight increase of 15% by IHC and 25% by 
Western blotting was observed among acetone treated exercised mice. After TPA treatment, the 
increase of IGFBP-3 in exercise group was not significant as detected by IHC, but significant by 
Western blotting. In terms of PTEN protein level (Figure 2-5), a significant increase of 207% by 
IHC but not Western blotting was found in exercised animal with acetone treatment. Under TPA 
treatment, both IHC and Western blotting showed significant increase by 89 % and 18%, 
respectively.  
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Interactive effects of Exercise and TPA on p53 regulator and transcription proteins  
The exercise and TPA interactive effects were further investigated on the five targeted 
proteins, MDM2, p53, p21, IGFBP-3 and PTEN. To analyze this interaction, protein levels 
between sedentary control under Acetone vehicle treatment (Sed+Ace) and exercise group under 
TPA treatment (Ex+TPA) were compared statistically. A significant decrease of MDM2 and 
increase of p53 was found under the intervention of exercise and TPA. However, the p53 
downstream proteins p21, IGFBP-3 and PTEN showed a potential but not significant increase 
under this intervention.  
 
Discussion 
The aim of this study was to illustrate a potential mechanism of cancer prevention by 
exercise. Previous work found exercise might reduce cancer risk through decreasing circulating 
IGF-1 and IGF-1signaling pathway in skin carcinogenesis mice (Xie et al., 2007; Standard et al., 
2014). To further investigate this mechanism, this study was focused on the impact of moderate 
exercise on selective IGF-1 related regulators in mice treated with pair-feeding, moderate 
exercise, and TPA. In this study, isocaloric diet was utilized to eliminate diet impact on test 
results, as energy expenditure from exercise might be compensated by free access to diet. 
Previous study in our lab (Xie et al., 2007; Standard et al., 2014) on weight-loss-induced cancer 
prevention by dietary calorie restriction and/or exercise found that exercise with ad libitum 
feeding was not sufficient in reducing body weight, therefore had limited or no effect on 
biomarkers involved in cellular growth regulation. When dietary intake in exercise mice was 
limited to the same amount as sedentary control, however, significant results were observed. 
Furthermore, exercise intensity and duration were also taken into consideration in this study. 
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Most studies reported a dose-response effect that increased intensity and prolonged duration 
provide greater protection against cancer risk (Friedenreich et al., 2010; Lynch et al., 2011). A 
moderate intensity treadmill exercise at 20 m/min, 60 min/day and 5 days/week for 10 weeks 
was employed to ensure the sufficiency and accessibility of exercise. In addition, a 2-hour TPA 
promotion period was selected, as optimal induction in AP-1: DNA binding and c-Jun mRNA 
was observed in a previous time-course study (Przybyszewski et al., 2001). 
To better understand the regulation of IGF-1 pathway, protein p53 and its down-stream 
proteins were examined. As expected, a significant increase in p53 protein and decrease in 
MDM2 protein were observed in exercised mouse compared to sedentary control. Particularly, 
the exercise-induced p53 enhancement increased largely to 159% after TPA promotion. This is 
consistent with a recent study by Higgins et al. that reported a dramatic increase of p53 protein 
(1103%) in mice lung tumors after a four-week wheel running exercise (Higgins et al., 2014). 
The reduction of MDM2 together with increase of p53 indicated that p53 might be activated 
following exercise. The activation of p53 was further confirmed by the increase of its direct-
regulated downstream protein p21, a cyclin/CDK cascade inhibitor (Xiong et al., 1993). The p53 
together with p21 has been reported to contribute to G1 cell cycle arrest (Waldman et al., 1995), 
therefore prevent cell growth in cancer development. 
In addition to p53, two critical p53 transcription proteins IGFBP-3 and PTEN showed 
significant increase after treadmill exercise. IGFBP-3 is the most abundant in IGF-1 binding 
protein family and accounts for approximately 90% of IGF-1 binding in serum, forming a large 
complex that prevents IGF-1 from transporting out of bloodstream (Jiang et al., 2008). Based on 
the current results, we assume that the competition binding of IGFBP-3 with IGF-1 to IGF-1 
receptor might contribute to reduced IGF-1signaling. Although the IGF-1 levels were not 
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detected in this study, previous studies from our laboratory observed significant decrease in IGF-
1 in exercised mice (Xie et al., 2007). The p53-dependent enhancement of IGFBP-3 has been 
supported in a p53 knockout study (Buckbinder et al., 1995). In addition to IGFBP-3, the 
increase of phosphoprotein PTEN appears to bridge p53 with IGF-1 pathway following exercise. 
PTEN is known to retain IGF-1-PI3K-AKT pathway by dephosphorylating PIP3 back to PIP2 
(Lu et al., 2006). The p53 regulated PTEN elevation has also been reported (Stambolic et al., 
2001). As such, exercise-activated p53 might inhibit IGF-1 pathway through promoting IGFBP-
3-IGF-1 binding as well as increasing PTEN negative regulation. 
The impact of exercise on target protein expression was compared under both TPA 
treatment and basal level. Considering the significant roles of p53 and p53 related proteins in 
tumor suppression, it would be of interest to know the effect not only in a TPA induced cancer 
development circumstance, but also in a basal level of normal condition. In general, all the target 
proteins showed significant change following exercise in both TPA promotion and basal level. 
Furthermore, an intervention between exercise and TPA was observed on the decrease of MDM2 
and increase of p53. The significant change in MDM2 and p53 confirmed the critical role of p53 
after DNA damage particularly during cancer development, suggesting a larger protective effect 
of exercise on high cancer risk than that in normal or low cancer risk. 
In this study, each protein was quantified using the same primary antibody by both IHC 
and Western blotting methods. Consistency in protein change was demonstrated for protein 
MDM2, p53, and p21 by IHC and Western blotting, whereas the change for IGFBP-3 and PTEN 
was not consistent between the two methods. IHC did not show a significant increase of IGFBP-
3 under TPA treatment, but it provided a general distribution of each protein in addition to 
quantification. The basal level of PTEN expression, on the other hand, did not significantly 
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detected by Westerns blotting. Although Western blotting is generally more quantitative and 
sensitive than IHC, it should be noted the skin epidermis might be diluted by other types of cells 
and thus cause some variation. 
In conclusion, the current study demonstrated a potential protective effects of exercise on 
mouse skin cancer by modulation of p53-IGF-1 signaling pathway. As summarized in Figure 2-
6, exercise might exert its function through activating p53 by reducing MDM2, subsequently 
leading to over-expression of p21, IGFBP-3 and PTEN. Both IGFBP-3 and PTEN may further 
reduce circulating IGF-1 and IGF-1-dependent pathway, respectively. A negative regulation of 
IGF-1 pathway through p53 activation and p53-related regulators may thus inhibit cell 
proliferation and promote apoptosis, as a result, contribute to the exercise-induced cancer 
prevention in this mouse skin cancer model.  
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Figures 
 
Figure 2-1 MDM2 protein expression 
 
(A). MDM2 protein fluorescence intensity measured by IHC. (B). MDM2 protein expression 
measured by Western blotting. Sed = Sedentary; Ex = Exercised; Ace = Acetone; TPA = 12-O-
tetradecanoylphorbol-13-acetate. Data presented are mean  SD. *p<0.05 as compared to 
corresponding sedentary control under acetone or TPA, respectively. 
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Figure 2-2 p53 protein expression  
 
 (A). p53 protein fluorescence intensity measured by IHC. (B). p53 protein expression measured 
by Western blotting. Sed = Sedentary; Ex = Exercised; Ace = Acetone; TPA = 12-O-
tetradecanoylphorbol-13-acetate. Data presented are mean  SD. *p<0.05 as compared to 
corresponding sedentary control under acetone or TPA, respectively. 
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Figure 2-3 p21 protein expression 
 
(A). p21 protein fluorescence intensity measured by IHC. (B). p21 protein expression measured 
by Western blotting. Sed = Sedentary; Ex = Exercised; Ace = Acetone; TPA = 12-O-
tetradecanoylphorbol-13-acetate. Data presented are mean  SD. *p<0.05 as compared to 
corresponding sedentary control under acetone or TPA, respectively. 
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Figure 2-4 IGFBP-3 protein expression 
 
(A). IGFBP-3 protein fluorescence intensity measured by IHC. (B). IGFBP-3 protein expression 
measured by Western blotting. Sed = Sedentary; Ex = Exercised; Ace = Acetone; TPA = 12-O-
tetradecanoylphorbol-13-acetate. Data presented are mean  SD. *p<0.05 as compared to 
corresponding sedentary control under acetone or TPA, respectively. 
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Figure 2-5 PTEN protein expression 
 
(A). PTEN protein fluorescence intensity measured by IHC. (B). PTEN protein expression 
measured by Western blotting. Sed = Sedentary; Ex = Exercised; Ace = Acetone; TPA = 12-O-
tetradecanoylphorbol-13-acetate. Data presented are mean  SD. *p<0.05 as compared to 
corresponding sedentary control under acetone or TPA, respectively. 
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Figure 2-6 Molecular mechanism of cancer prevention via p53-IGF-1 pathway  
 
Exercise may activate p53 by inhibiting MDM2 suppression, subsequently enhance the 
expression of p21, IGFBP-3 and PTEN. Both IGFBP-3 and PTEN may further reduce circulating 
IGF-1 and IGF-1-dependent pathway, respectively. A negative regulation of IGF-1 pathway 
through p53 activation and p53-related proteins may thus inhibit TPA induced cell proliferation 
and promote cell apoptosis, therefore contribute to the exercise-induced cancer prevention in this 
mouse skin cancer model. 
 
